Table 2.
Sociodemographic, physical, and psychosocial features of FGID patients.
| Effective n | FGID patients in total (n = 271)∗ [20] | Patients with 1 FGID diagnosis (n = 141) | Patients with >1 FGID diagnoses (n = 130)∗∗ | p value | |
|---|---|---|---|---|---|
| Sociodemographic characteristics | |||||
| Age—years2 | 271 | 38.00 [23.00] | 39.00 [24.00] | 35.50 [24.00] | 0.548c |
| Gender—female, n (%) | 271 | 195 (72.00) | 96 (68.09) | 99 (76.15) | 0.140b |
| Nationality—German, n (%) | 265 | 249 (94.00) | 130 (95.59) | 119 (92.25) | 0.254b |
| Marital status—with a partner, n (%) | 271 | 152 (56.10) | 81 (57.45) | 71 (54.62) | 0.639b |
| Educational level—ISCED ≤2, n (%) | 271 | 126 (46.50) | 65 (46.10) | 61 (46.92) | 0.892b |
| Paid employment, n (%) | 271 | 144 (53.10) | 77 (54.61) | 67 (51.54) | 0.613b |
| Old-age pension, n (%) | 271 | 32 (11.81) | 15 (10.64) | 17 (13.08) | 0.534b |
| Disability pension, n (%) | 271 | 8 (3.00) | 3 (2.13) | 5 (3.85) | 0.486b |
| Gastrointestinal symptoms | |||||
| Symptom duration—months2 | 255 | 48.00 [101.00] | 48.00 [76.00] | 48.00 [101.00] | 0.548c |
| Symptom severity (IBS-SSS)2 | 267 | 290.00 [169.00] | 232.00 [162.50] | 339.00 [126.00] | <0.001 c |
| Stool consistency | |||||
| Loose (BSFS 1, 2), n (%) | 266 | 190 (71.43) | 100 (72.46) | 90 (70.31) | 0.698 |
| Normal (BSFS 3, 4), n (%) | 266 | 126 (47.37) | 64 (46.38) | 62 (48.44) | 0.737 |
| Hard (BSFS 5, 6, 7), n (%) | 266 | 86 (32.33) | 45 (32.61) | 41 (32.03) | 0.920 |
| Any mental disorder, n (%) | 250 | 188 (75.20) | 92 (71.88) | 96 (78.69) | 0.212b |
| Somatization (PHQ-15) | |||||
| Any somatoform syndrome, n (%) | 255 | 166 (65.10) | 79 (60.77) | 87 (69.60) | 0.139b |
| PHQ-15 (range 0-30)2 | 250 | 13.00 [7.00] | 12.00 [6.41] | 14.00 [5.98] | 0.008 c |
| PHQ-12 (range 0-24)2 | 250 | 8.00 [5.71] | 7.00 [5.00] | 8.00 [5.00] | 0.028 c |
| SSS-8 (range 0-32)2 | 261 | 13.00 [9.07] | 11.43 [9.00] | 14.00 [10.00] | 0.001 c |
| Depression (PHQ-9) | |||||
| Any depressive syndrome, n (%) | 262 | 108 (41.22) | 56 (41.48) | 52 (40.94) | 0.930b |
| Major depressive syndrome, n (%) | 263 | 66 (25.10) | 36 (26.67) | 30 (23.43) | 0.546b |
| Other depressive syndrome, n (%) | 263 | 42 (15.97) | 20 (14.81) | 22 (17.19) | 0.600b |
| PHQ-9 (range 0-27)2 | 269 | 9.00 [7.37] | 8.00 [8.00] | 9.00 [7.50] | 0.189c |
| Anxiety (GAD-7; PHQ panic module) | |||||
| Any anxiety syndrome, n (%) | 258 | 48 (18.60) | 24 (18.18) | 24 (19.05) | 0.858b |
| Other anxiety syndrome, n (%) | 259 | 30 (11.58) | 15 (11.36) | 15 (11.81) | 0.910b |
| Panic syndrome, n (%) | 263 | 27 (10.27) | 15 (11.11) | 12 (9.38) | 0.643b |
| GAD-7 (range 0-21)2 | 267 | 7.00 [8.00] | 7.00 [8.50] | 7.00 [8.00] | 0.725c |
| Other psychosocial features | |||||
| Illness anxiety (WI-7; range 0-28)2 | 264 | 11.00 [10.00] | 10.00 [10.00] | 13.00 [10.25] | 0.022 c |
| Any eating disorder, n (%) | 261 | 27 (10.00) | 16 (11.35) | 11 (8.46) | 0.428b |
| Abuse (Rome III), n (%) | 253 | 48 (18.97) | 19 (14.50) | 29 (23.77) | 0.060b |
| Suicidality (Rome III), n (%) | 259 | 52 (20.07) | 25 (18.80) | 27 (21.43) | 0.597b |
| Quality of life | |||||
| FDD-QoL1 | 258 | 48.32 (15.27) | 51.45 (15.20) | 45.09 (14.72) | 0.001 a |
| Activities2 | 270 | 53.34 [40.63] | 59.38 [41.29] | 45.31 [39.17] | <0.001 c |
| Anxiety2 | 266 | 55.00 [38.13] | 55.00 [41.25] | 50.00 [40.00] | 0.403c |
| Diet2 | 265 | 37.50 [37.50] | 41.67 [44.17] | 33.33 [37.50] | 0.003 c |
| Sleep2 | 265 | 75.00 [41.67] | 75.00 [33.33] | 66.67 [33.33] | 0.019 c |
| Discomfort2 | 264 | 38.89 [25.00] | 43.75 [27.78] | 36.11 [23.61] | 0.002 c |
| Health perception2 | 262 | 37.50 [29.17] | 40.00 [33.33] | 33.33 [22.92] | 0.021 c |
| Disease coping2 | 261 | 41.67 [33.33] | 41.67 [33.33] | 33.33 [29.17] | 0.173c |
| Stress2 | 262 | 41.67 [41.67] | 50.00 [41.67] | 41.67 [41.67] | 0.553c |
| SF-36 | |||||
| Physical QoL1 | 250 | 40.44 (9.83) | 42.99 (9.77) | 37.64 (9.15) | <0.001 a |
| Mental QoL2 | 250 | 39.29 [21.02] | 39.89 [22.06] | 38.54 [19.89] | 0.781c |
1Mean (standard deviation). 2Median [interquartile range]. at-test. bχ2 test. cMann–Whitney U test. ∗Most of the data of the column with FGID patients in total were shown similarly in Berens et al. [20]. ∗∗All patients with >1 FGID diagnoses had two FGIDs.